Web Results

Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings - April 26 ...

www.zacks.com/stock/news/214810/biotech-stock-gilead-gild-likely-to-beat-in-q1-earnings

Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 results on ... Gilead's blockbuster hepatitis C virus (HCV) drug Harvoni should ... Here are a couple of other health care stocks that you may want to ... Biotech Stock Roundup : Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure.

Gilead Sciences: After Hepatitis C Court Victory, an Earnings Boost ...

blogs.barrons.com/stockstowatchtoday/2016/06/08/gilead-sciences-after-hepatitis-c-court-victory-an-earnings-boost/

Jun 8, 2016 ... Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck ... property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. ... News and commentary about the stocks you need to know about today ... 2016 but generated only $50 million of sales in the first quarter of 2016.

Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact

finance.yahoo.com/news/gilead-gild-lags-q1-earnings-131901021.html

Apr 29, 2016 ... Gilead Sciences, Inc.'s GILD first-quarter 2016 earnings (including ... Gilead's blockbuster hepatitis C virus (HCV) drug, Harvoni, plunged ..... Apple Car rumor roundup: Here's everything you need to know about 'Project Titan'.

Biotech Stock Roundup: Amgen Impresses, Gilead Disappoints in ...

finance.yahoo.com/news/biotech-stock-roundup-amgen-impresses-171105755.html

May 4, 2016 ... Big names in the biotech sector reported earnings over the last five trading days ... Vertex's first quarter results were also disappointing with the ... According to AbbVie, the candidate has blockbuster potential and could ..... Apple Car rumor roundup: Here's everything you need to know about 'Project Tita...

Corrected AbbVie's $84000 question - Crain's Chicago Business

www.chicagobusiness.com/article/20140510/ISSUE01/305109990/abbvies-84-000-question

May 10, 2014 ... Gilead's windfall is no doubt figuring into AbbVie's strategy for how it introduces its own treatment in the fourth quarter. ... “When you look at the attributes of this product, the performance speaks for itself,” he told analysts in January. ... the rheumatoid arthritis blockbuster that starts going off patent...

The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen ...

www.nasdaq.com/article/the-zacks-analyst-blog-highlights-biogen-gilead-abbvie-amgen-and-celgene-cm656426

1 day ago ... 5 Reasons You Should Be a Long-Term Investor ... Biotech Stock Roundup: Q2 Earnings Beats ... second quarter results over the last few days - Biogen and Gilead. ... of the label of its blockbuster drug, Revlimid, as maintenance treatment in a ... Today, you can download 7 Best Stocks for the Next 30 Days.

Drug Channels: Why Blockbuster Hepatitis C Drugs Are Squeezing ...

www.drugchannels.net/2015/02/why-blockbuster-hepatitis-c-drugs-are.html

Feb 10, 2015 ... Read on and see if you agree with my slap and tickle math. ... what Hammergren disclosed during McKesson's October 2014 earnings call: ... In McKesson's second 2015 fiscal quarter (2014's third calendar ... Consider Gilead Sciences' Sovaldi, the hepatitis C drug approved in ..... Weekly Roundup 7.22.16.

Regulatory Recon: Baxter, Lilly Beat Sales Estimates; Gilead Lowers ...

www.raps.org/Regulatory-Focus/News/2016/07/26/25392/Regulatory-Recon-Baxter-Lilly-Beat-Sales-Estimates;-Gilead-Lowers-Guidance-Amid-Lower-HCV-Sales-26-July-2016/

2 days ago ... Regulatory Recon: Baxter, Lilly Beat Sales Estimates; Gilead Lowers ... (STAT); Gilead Readying for Earnings Report , Lowers 2016 Guidance Amid Slowing ... use among Medicaid children with asthma (Health Marketing Quarterly) ... Each weekday morning, we aim to bring you the latest highlights of new ...

3 Things to Watch With Gilead Sciences - The Motley Fool

www.fool.com/investing/general/2012/07/09/3-things-to-watch-with-gilead-sciences.aspx

Jul 9, 2012 ... These factors could hold the key to big gains with Gilead Sciences. ... $1.84 billion of Gilead's $2.21 billion in net product sales in the first-quarter. ... Just in case you weren't aware, the race to create the next blockbuster ... Foolish roundup. Now that you know what to watch for, it should be easier to an...

Friday, April 29, 2016 | Kaiser Health News

khn.org/morning-briefing/friday-april-29-2016/

Apr 29, 2016 ... Health Policy Research; Research Roundup: New Medicare Doc Pay; ... Keep in mind that we give extra points if you link back to a KHN original story. ..... Aetna's first-quarter earnings slid nearly 7 percent as enrollment ... The drugmaker Gilead Sciences has seen its fortunes buoyed by its blockbuster ...

More Info

What to look for in Gilead earnings - MarketWatch

www.marketwatch.com

Apr 30, 2015 ... How much of a role will the blockbuster Hepatitis C drugs, Sovaldi and Harvoni, play ... Need to Know Analyst Ratings EarningsWatch ... Gilead, however, had adjusted income of $2.43 last quarter, more than quadruple ... For now, though, if you presume that the FactSet prediction of $6.89 billion is close to ...

Gilead 1Q profit tumbles on slower hepatitis C drug sales

finance.yahoo.com

Apr 28, 2016 ... Gilead Science Inc.'s earnings tumbled more than 17 percent in the first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut ... Apple Car rumor roundup: Here's everything you need to know about ...

Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug ...

finance.yahoo.com

Jun 29, 2016 ... Meanwhile, Gilead continues to expand its blockbuster HCV franchise. ... and will focus on submitting a NDA in the fourth quarter of 2016. .... what's left is a core, fundamental outlook for earnings and FCF that we think is .... Apple Car rumor roundup: Here's everything you need to know about 'Project Tita...